AbCellera Biologics Inc. - Ordinary Shares (ABCL)

CUSIP: 00288U106

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Ordinary Shares
Shares outstanding
293,061,432
Total 13F shares
120,025,395
Share change
-4,812,980
Total reported value
$551,791,208
Put/Call ratio
37%
Price per share
$4.60
Number of holders
137
Value change
-$29,473,838
Number of buys
56
Number of sells
87

Quarterly Holders Quick Answers

What is CUSIP 00288U106?
CUSIP 00288U106 identifies ABCL - AbCellera Biologics Inc. - Ordinary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AbCellera Biologics Inc. - Ordinary Shares (ABCL) as of Q3 2023

As of 30 Sep 2023, AbCellera Biologics Inc. - Ordinary Shares (ABCL) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 120,025,395 shares. The largest 10 holders included BAILLIE GIFFORD & CO, BAKER BROS. ADVISORS LP, Voya Investment Management LLC, Capital World Investors, CREDIT SUISSE AG/, ORBIMED ADVISORS LLC, ArrowMark Colorado Holdings LLC, Founders Fund VII Management, LLC, BlackRock Inc., and FEDERATED HERMES, INC.. This page lists 137 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.